We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Ferguson
FERG
$45B
| $1.54M | ﹤0.01% |
12,230
+950
| +8% | +$111K |
|
877
NIO
NIO
$11.7B
| $1.54M | ﹤0.01% |
97,550
| – | – |
|
878
Relmada Therapeutics
RLMD
$549M
| $1.54M | ﹤0.01% |
41,530
+41,170
| +11,436% | +$1.14M |
|
879
Valvoline
VVV
$5.13B
| $1.54M | ﹤0.01% |
60,597
-5,940
| -9% | -$174K |
|
880
Oshkosh
OSK
$9.51B
| $1.53M | ﹤0.01% |
21,800
-48,665
| -69% | -$3.96M |
|
|
SYNH
881
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.53M | ﹤0.01% |
32,443
-5,900
| -15% | -$381K |
|
882
Eaton
ETN
$150B
| $1.53M | ﹤0.01% |
11,459
-940
| -8% | -$132K |
|
|
APLS
883
DELISTED
Apellis Pharmaceuticals
APLS
| $1.52M | ﹤0.01% |
22,330
-117,829
| -84% | -$6.97M |
|
884
Synaptics
SYNA
$4.33B
| $1.52M | ﹤0.01% |
15,396
+2,405
| +19% | +$298K |
|
885
Rollins
ROL
$18.8B
| $1.52M | ﹤0.01% |
43,740
+21,690
| +98% | +$783K |
|
886
UMB Financial
UMBF
$10.9B
| $1.51M | ﹤0.01% |
17,930
| – | – |
|
887
Asbury Automotive
ABG
$4.49B
| $1.5M | ﹤0.01% |
9,944
-2,890
| -23% | -$492K |
|
888
MGIC Investment
MTG
$6.47B
| $1.5M | ﹤0.01% |
116,960
| – | – |
|
889
Aptiv
APTV
$12.6B
| $1.5M | ﹤0.01% |
19,110
-1,861
| -9% | -$179K |
|
890
IDEAYA Biosciences
IDYA
$3.48B
| $1.5M | ﹤0.01% |
100,171
+5,390
| +6% | +$70K |
|
891
Hawaiian Electric Industries
HE
$2.28B
| $1.49M | ﹤0.01% |
42,989
-41,095
| -49% | -$1.65M |
|
892
Yum China
YUMC
$15.6B
| $1.49M | ﹤0.01% |
31,450
-800
| -2% | -$38.4K |
|
893
FTAI Infrastructure
FIP
$482M
| $1.49M | ﹤0.01% |
+619,993
| New | +$1.77M |
|
894
MKS Inc
MKSI
$19.3B
| $1.49M | ﹤0.01% |
17,983
-970
| -5% | -$99.9K |
|
895
DXC Technology
DXC
$1.76B
| $1.48M | ﹤0.01% |
60,570
| – | – |
|
|
SGI
896
Somnigroup International
SGI
$15.2B
| $1.48M | ﹤0.01% |
61,408
-56,570
| -48% | -$1.47M |
|
|
IAA
897
DELISTED
IAA, Inc. Common Stock
IAA
| $1.48M | ﹤0.01% |
46,340
-940
| -2% | -$33.4K |
|
898
Moody's
MCO
$83.9B
| $1.47M | ﹤0.01% |
6,061
+490
| +9% | +$142K |
|
899
Saia
SAIA
$10.9B
| $1.47M | ﹤0.01% |
7,739
-1,890
| -20% | -$401K |
|
|
WRK
900
DELISTED
WestRock Company
WRK
| $1.47M | ﹤0.01% |
47,542
+350
| +0.7% | +$13.8K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.